|
|
|
|
Vol. 63, Issue 5, 1021-1031, May 2003
Molecular Recognition Section, Laboratory of Bioorganic Chemistry,
National Institute of Diabetes and Digestive and Kidney Diseases,
National Institutes of Health, Department of Health and Human Services,
Bethesda, Maryland
We examined the effects on allosteric modulation and ligand binding of
the mutation of amino acid residues of the human A3 adenosine receptor (A3AR) that are hypothesized to be near
one of three loci: the putative sodium binding site, the putative ligand binding site, and the DRY motif in transmembrane helical domain
3. The effects of three heterocyclic allosteric modulators [the
imidazoquinoline
2-cyclopentyl-4-phenylamino-1H-imidazo[4,5-c]quinoline (DU124183), the pyridinylisoquinoline
4-methoxy-N-[7-methyl-3-(2-pyridinyl)-1-isoquinolinyl]benzamide (VUF5455), and the amiloride analog
5-(N,N-hexamethylene)-amiloride] on the
dissociation of the agonist radioligand,
N6- (4-amino-3-[125I]iodobenzyl)-5'-N-methylcarboxamidoadenosine,
were compared at wild-type (WT) and mutant A3ARs. The
F182A5.43 and N274A7.45 mutations eliminated
the allosteric effects of all three modulators but had little effect on
agonist binding. The N30A1.50 and D58N2.50
mutations abolished the allosteric effects of DU124183 and VUF5455, but
not HMA, whereas the D107N3.49 mutation abolished the
effects of DU124183, but not HMA or VUF5455. The T94A3.36,
H95A3.37, K152AEL2, W243A6.48,
L244A6.49, and S247A6.52 mutations did not
influence allosteric effects of the modulators. Sodium ions (100 mM),
which modulate agonist binding at a variety of receptors, caused an
~80% inhibition of agonist binding in WT A3ARs but did
not show any effect on D58N2.50, D107N3.49, and
F182A5.43 mutant receptors. In contrast, NaCl induced a
modest increase of agonist binding in N30A1.50 and
N274A7.45 mutant receptors. NaCl decreased the dissociation
rate of the antagonist radioligand
[3H]8-ethyl-4-methyl-2-phenyl-(8R)-4,5,7,8-tetrahydro-1H-imidazo[2.1-i]purin-5-one (PSB-11) at the WT A3ARs, but not the D58N2.50
mutant receptor. The results were interpreted using a rhodopsin-based molecular model of the A3AR to suggest multiple binding
modes of the allosteric modulators.
This article has been cited by other articles:
![]() |
B. Holst, T. M. Frimurer, J. Mokrosinski, T. Halkjaer, K. B. Cullberg, C. R. Underwood, and T. W. Schwartz Overlapping Binding Site for the Endogenous Agonist, Small-Molecule Agonists, and Ago-allosteric Modulators on the Ghrelin Receptor Mol. Pharmacol., January 1, 2009; 75(1): 44 - 59. [Abstract] [Full Text] [PDF] |
||||